A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Recruiting now · Phase 2

Conditions studied: Surgery, Nerve Injury, Imaging

In brief

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Key facts

Study ID

NCT06662097

Run by

Alume Biosciences, Inc.

People needed

64

Starts

2024-10-16

Expected to finish

2025-09-01

Last updated by the study team

2024-10-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be a minimum of 18 years of age
• Study participant is planning to proceed with surgery
• Willing to provide informed consent
• Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after.
• Females of childbearing potential must have a negative pregnancy test at screening and during the study.

You may not qualify if…

• Patient has had prior surgery at the intended surgical site.
• Patient has abnormal cardiac rhythm not controlled by medication.
• Patient has moderate to severe renal impairment.
• Patient has a history of fluorescein allergy.
• Patient has a history of drug-related anaphylactic.
• Presence of a concurrent disease or condition that may interfere with study participation.
• Presence or history of any condition that, in the view of the investigator, places the patient at high risk of treatment compliance.
• Use of any Investigational Product or investigational medial device within 30 days prior to screening.

Where it is running

• University of California San Diego — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.